Evidence map›Paper›PMID 24146948›Full record

ArticlePloS one2013

The transcriptional repressor domain of Gli3 is intrinsically disordered.

Robert Tsanev, Kalju Vanatalu, Jüri Jarvet, Risto Tanner, Kristi Laur, Piret Tiigimägi, Birthe B Kragelund, Torben Østerlund, Priit Kogerman

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. NovelPathology oncology research : POR · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Robert TsanevDepartment of Gene Technology, Tallinn University of Technology, Tallinn, Estonia.
Kalju Vanatalu
Jüri Jarvet
Risto Tanner
Kristi Laur
Piret Tiigimägi
Birthe B Kragelund
Torben Østerlund
Priit Kogerman
Tallinn University of Technology · EENational Institute of Chemical Physics and Biophysics · EEUniversity of Copenhagen · DKZealand Pharma (Denmark) · DK

Funding

Wellcome Trust
6 · The paper itself

Abstract

The transcription factor Gli3 is acting mainly as a transcriptional repressor in the Sonic hedgehog signal transduction pathway. Gli3 contains a repressor domain in its N-terminus from residue G106 to E236. In this study we have characterized the intracellular structure of the Gli3 repressor domain using a combined bioinformatics and experimental approach. According to our findings the Gli3 repressor domain while being intrinsically disordered contains predicted anchor sites for partner interactions. The obvious interaction partners to test were Ski and DNA; however, with both of these the structure of Gli3 repressor domain remained disordered. To locate residues important for the repressor function we mutated several residues within the Gli3 repressor domain. Two of these, H141A and H157N, targeting predicted helical regions, significantly decreased transcriptional repression and thus identify important functional parts of the domain.

Indexed as

Protein Interaction Domains and MotifsAmino Acid SequenceCell LineDNA-Binding ProteinsHumansIntrinsically Disordered ProteinsKruppel-Like Transcription FactorsMutationNerve Tissue ProteinsNuclear Magnetic Resonance, BiomolecularProtein BindingProto-Oncogene ProteinsRecombinant Fusion ProteinsRepressor ProteinsZinc Finger Protein Gli3DNA-Binding ProteinsGLI3 protein, humanIntrinsically Disordered ProteinsKruppel-Like Transcription FactorsNerve Tissue ProteinsProto-Oncogene ProteinsRecombinant Fusion ProteinsRepressor ProteinsSKI protein, humanZinc Finger Protein Gli3

Identifiers

PMID24146948
PMCPMC3798401
OpenAlexW2058859606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.